发明名称 |
Anticarcinogenic drug composition |
摘要 |
<p>The invention provides an anticarcinogenic drug composition which effectively inhibits the recurrence of hepatocellular carcinoma (the occurrence of second primary tumor), the occurrence of hepatocellular carcinoma in high risk groups with chronic hepatitis and liver cirrhosis, the occurrence of cervical carcinoma intraepitheliale, lung adenocarcinoma, lung squamous cell carcinoma, mammary tumor, and the like and is highly safe. The anticarcinogenic drug composition contains 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid or a salt thereof.</p> |
申请公布号 |
EP0847754(A1) |
申请公布日期 |
1998.06.17 |
申请号 |
EP19970121938 |
申请日期 |
1997.12.12 |
申请人 |
LEBER CO., LTD. |
发明人 |
MUTO, YASUTOSHI;MORIWAKI, HISATAKA;NINOMIYA, MITSUO;ADACHI, SADASHI;SAITO, AKIKO;TAKASAKI, TAKESHI;TANAKA, T.;TSURUMI, KAITO,;OKUNO, MASATAKA;TOMITA, EIICHI;NAKAMURA, TOSHIYUKI;KOJIMA, TAKAO |
分类号 |
A61K31/202;A61K31/19;A61P35/00;C07C57/03;(IPC1-7):A61K31/20 |
主分类号 |
A61K31/202 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|